(Q81375269)
Statements
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study (English)
Daniel L Clarke-Pearson
David R Spriggs
Mark F Brady
Luis Vaccarello
Robert A Burger
Robert Mannel
John F Boggess
Roger B Lee